Industry: Pharmaceuticals, Biotechnology
ReNeuron is a leading, UK-based adult stem cell therapy business. The Group is applying its novel stem cell platform technologies in the development of ground-breaking stem cell therapies to serve significant and unmet or poorly-met clinical needs. ReNeuron has used its c-mycERTAM technology to generate genetically stable neural stem cell lines. This technology platform has multi-national patent protection and is fully regulated by means of a chemically-induced safety switch. Cell growth can therefore be completely arrested prior to in vivo implantation. The Group’s lead stem cell therapy, ReN001 for chronic stroke disability, is in late pre-clinical ( www.reneuron.com )
ReNeuron Limited
10 Nugent Rd Surrey Research Park
Guildford, Surrey GU2 7AF
United Kingdom
Tel: +44 1483 302560
Fax: +44 1483 534864